These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 31112454)

  • 61. The study of Cutaneous Lupus Erythematosus Disease Area and Severity Index in Indian patients with systemic lupus erythematosus.
    Salphale P; Danda D; Chandrashekar L; Peter D; Jayaseeli N; George R
    Lupus; 2011 Dec; 20(14):1510-7. PubMed ID: 21997966
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Clinical aspects and differential diagnosis of cutaneous lupus erythematosus].
    Kind P; Goerz G
    Z Hautkr; 1987 Sep; 62(18):1337-8, 1341-2, 1347. PubMed ID: 3687157
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score.
    Braunstein I; Klein R; Okawa J; Werth VP
    Br J Dermatol; 2012 May; 166(5):971-5. PubMed ID: 22242767
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Systemic lupus erythematosus in patients with chronic cutaneous (discoid) lupus erythematosus. Clinical and laboratory findings in seventeen patients.
    Callen JP
    J Am Acad Dermatol; 1985 Feb; 12(2 Pt 1):278-88. PubMed ID: 3871800
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Late-onset cutaneous lupus erythematosus patients have distinctive clinical features and demographics versus early-onset patients.
    Anderson SR; Hynan LS; Chong BF
    Lupus; 2022 Oct; 31(12):1523-1528. PubMed ID: 35995793
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Expression pattern of tissue-resident memory T cells in cutaneous lupus erythematosus.
    Gu HJ; Song S; Roh JY; Jung Y; Kim HJ
    Lupus; 2021 Aug; 30(9):1427-1437. PubMed ID: 34013817
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lenalidomide treatment of cutaneous lupus erythematosus: the Mayo Clinic experience.
    Kindle SA; Wetter DA; Davis MD; Pittelkow MR; Sciallis GF
    Int J Dermatol; 2016 Aug; 55(8):e431-9. PubMed ID: 26873674
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Markers in cutaneous lupus erythematosus indicating systemic involvement. A multicenter study on 296 patients.
    Tebbe B; Mansmann U; Wollina U; Auer-Grumbach P; Licht-Mbalyohere A; Arensmeier M; Orfanos CE
    Acta Derm Venereol; 1997 Jul; 77(4):305-8. PubMed ID: 9228225
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Lupus Erythematosus Tumidus Clinical Characteristics and Treatment: A Retrospective Review of 25 Patients.
    Pona A; Cardenas-de la Garza JA; Broderick A; Sangueza OP; Niehaus AG; Bowers N; Pichardo RO
    Cutis; 2022 Jun; 109(6):330-332. PubMed ID: 35960984
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Varied responses to and efficacies of hydroxychloroquine treatment according to cutaneous lupus erythematosus subtypes in Japanese patients.
    Ototake Y; Yamaguchi Y; Kanaoka M; Akita A; Ikeda N; Aihara M
    J Dermatol; 2019 Apr; 46(4):285-289. PubMed ID: 30719729
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Apoptosis of keratinocytes and serum DNase I activity in patients with cutaneous lupus erythematosus: relationship with clinical and immunoserological parameters.
    Skiljevic D; Bonaci-Nikolic B; Brasanac D; Nikolic M
    J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):523-529. PubMed ID: 27557471
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical manifestations of cutaneous lupus erythematosus.
    Kuhn A; Sticherling M; Bonsmann G
    J Dtsch Dermatol Ges; 2007 Dec; 5(12):1124-37. PubMed ID: 18042093
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cutaneous lupus erythematosus: issues in diagnosis and treatment.
    Walling HW; Sontheimer RD
    Am J Clin Dermatol; 2009; 10(6):365-81. PubMed ID: 19824738
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Biological therapies in the treatment of cutaneous lupus erythematosus.
    Presto JK; Hejazi EZ; Werth VP
    Lupus; 2017 Feb; 26(2):115-118. PubMed ID: 27687023
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Systemic symptoms in the progression of cutaneous to systemic lupus erythematosus.
    Wieczorek IT; Propert KJ; Okawa J; Werth VP
    JAMA Dermatol; 2014 Mar; 150(3):291-6. PubMed ID: 24477339
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus.
    Chen KL; Krain RL; Werth VP
    F1000Res; 2019; 8():. PubMed ID: 30984372
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inflammatory and T Helper 17/ Regulatory T Cells Related Cytokines Balance in Cutaneous Lupus Erythematosus (CLE).
    Yazdani MR; Aflaki E; Gholijani N
    Iran J Allergy Asthma Immunol; 2020 Feb; 19(1):9-17. PubMed ID: 32245325
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dermoscopic Features of Acute, Subacute, Chronic and Intermittent Subtypes of Cutaneous Lupus Erythematosus in Caucasians.
    Żychowska M; Reich A
    J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887849
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Köbner phenomenon in lupus erythematosus].
    Ueki H
    Hautarzt; 1994 Mar; 45(3):154-60. PubMed ID: 8175343
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Increased risk of depression in patients with cutaneous lupus erythematosus and systemic lupus erythematosus: a Danish nationwide cohort study.
    Hesselvig JH; Egeberg A; Kofoed K; Gislason G; Dreyer L
    Br J Dermatol; 2018 Nov; 179(5):1095-1101. PubMed ID: 29885269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.